Cargando…
Mini-Review: PDPK1 (3-phosphoinositide dependent protein kinase-1), An Emerging Cancer Stem Cell Target
Cancer stem cells (CSCs) are subpopulations of tumor cells that possess abilities for self-renewal, differentiation, and tumor initiation. These rare but therapy-recalcitrant cells are assumed to repopulate tumors following administration of systemic chemotherapy driving therapy failure, tumor recur...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8168947/ https://www.ncbi.nlm.nih.gov/pubmed/34079928 http://dx.doi.org/10.29245/2578-2967/2021/1.1194 |
_version_ | 1783701960258486272 |
---|---|
author | Domrachev, Bogdan Singh, Sitanshu Li, Dandan Rudloff, Udo |
author_facet | Domrachev, Bogdan Singh, Sitanshu Li, Dandan Rudloff, Udo |
author_sort | Domrachev, Bogdan |
collection | PubMed |
description | Cancer stem cells (CSCs) are subpopulations of tumor cells that possess abilities for self-renewal, differentiation, and tumor initiation. These rare but therapy-recalcitrant cells are assumed to repopulate tumors following administration of systemic chemotherapy driving therapy failure, tumor recurrence, and disease progression. In early clinical trials, anti-CSC therapies have found limited success to-date possibly due to the inherent heterogeneity and plasticity of CSCs and the incomplete characterization of essential CSC targets. Here, we review the role of 3-phosphoinositide dependent protein kinase-1 (PDPK1) as an emerging CSC target. While most previous studies have relied on CSC models which are based on lineage and tissue-specific marker profiles to define the relationships between putative target and CSC traits, this review discusses PDPK1 and its role in CSC biology with an emphasis on CSC systems which are based on proposed function like label-retaining cancer cells (LRCCs). |
format | Online Article Text |
id | pubmed-8168947 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
record_format | MEDLINE/PubMed |
spelling | pubmed-81689472021-06-01 Mini-Review: PDPK1 (3-phosphoinositide dependent protein kinase-1), An Emerging Cancer Stem Cell Target Domrachev, Bogdan Singh, Sitanshu Li, Dandan Rudloff, Udo J Cancer Treatment Diagn Article Cancer stem cells (CSCs) are subpopulations of tumor cells that possess abilities for self-renewal, differentiation, and tumor initiation. These rare but therapy-recalcitrant cells are assumed to repopulate tumors following administration of systemic chemotherapy driving therapy failure, tumor recurrence, and disease progression. In early clinical trials, anti-CSC therapies have found limited success to-date possibly due to the inherent heterogeneity and plasticity of CSCs and the incomplete characterization of essential CSC targets. Here, we review the role of 3-phosphoinositide dependent protein kinase-1 (PDPK1) as an emerging CSC target. While most previous studies have relied on CSC models which are based on lineage and tissue-specific marker profiles to define the relationships between putative target and CSC traits, this review discusses PDPK1 and its role in CSC biology with an emphasis on CSC systems which are based on proposed function like label-retaining cancer cells (LRCCs). 2021-04-30 /pmc/articles/PMC8168947/ /pubmed/34079928 http://dx.doi.org/10.29245/2578-2967/2021/1.1194 Text en https://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution 4.0 International License. |
spellingShingle | Article Domrachev, Bogdan Singh, Sitanshu Li, Dandan Rudloff, Udo Mini-Review: PDPK1 (3-phosphoinositide dependent protein kinase-1), An Emerging Cancer Stem Cell Target |
title | Mini-Review: PDPK1 (3-phosphoinositide dependent protein kinase-1), An Emerging Cancer Stem Cell Target |
title_full | Mini-Review: PDPK1 (3-phosphoinositide dependent protein kinase-1), An Emerging Cancer Stem Cell Target |
title_fullStr | Mini-Review: PDPK1 (3-phosphoinositide dependent protein kinase-1), An Emerging Cancer Stem Cell Target |
title_full_unstemmed | Mini-Review: PDPK1 (3-phosphoinositide dependent protein kinase-1), An Emerging Cancer Stem Cell Target |
title_short | Mini-Review: PDPK1 (3-phosphoinositide dependent protein kinase-1), An Emerging Cancer Stem Cell Target |
title_sort | mini-review: pdpk1 (3-phosphoinositide dependent protein kinase-1), an emerging cancer stem cell target |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8168947/ https://www.ncbi.nlm.nih.gov/pubmed/34079928 http://dx.doi.org/10.29245/2578-2967/2021/1.1194 |
work_keys_str_mv | AT domrachevbogdan minireviewpdpk13phosphoinositidedependentproteinkinase1anemergingcancerstemcelltarget AT singhsitanshu minireviewpdpk13phosphoinositidedependentproteinkinase1anemergingcancerstemcelltarget AT lidandan minireviewpdpk13phosphoinositidedependentproteinkinase1anemergingcancerstemcelltarget AT rudloffudo minireviewpdpk13phosphoinositidedependentproteinkinase1anemergingcancerstemcelltarget |